Curing HIV: Seeking to Target and Clear Persistent Infection.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32220311.
- Also identified by DOI 10.1016/j.cell.2020.03.005 and PMC identifier 7896558.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human immunodeficiency virus type 1 (HIV-1) infection persists despite years of antiretroviral therapy (ART). To remove the stigma and burden of chronic infection, approaches to eradicate or cure HIV infection are desired. Attempts to augment ART with therapies that reverse viral latency, paired with immunotherapies to clear infection, have advanced into the clinic, but the field is still in its infancy. We review foundational studies and highlight new insights in HIV cure research. Together with advances in ART delivery and HIV prevention strategies, future therapies that clear HIV infection may relieve society of the affliction of the HIV pandemic.
Medical subject headings
- Anti-HIV Agents
- Chronic Disease
- HIV Infections
- HIV-1
- Immunotherapy
- Virus Latency